by Jessica Casebolt | Apr 14, 2023 | Opioid/Substance Use Disorders, Tea Leaves
The U.S. Food and Drug Administration said that it will require new safety warnings to be added in the prescribing information on labels for opioid pain relievers, including a warning about increased sensitivity to pain. FDA said data suggests patients who use opioids...
by Jessica Casebolt | Apr 14, 2023 | Mental Health, Tea Leaves
Suicide rates in the U.S. rose in 2021 after two years in decline, federal data showed, driven by more deaths among men in nearly every age group. Suicides rates increased 4% in 2021 from a year earlier to 14.1 deaths per 100,000 people, the National Center for Health...
by Jessica Casebolt | Apr 14, 2023 | Life Sciences, Tea Leaves
Pharmacy benefit management giant Express Scripts is rolling out multiple new programs in a bid to evolve its model to be more transparent and predictable for patients and plan sponsors. The company, a subsidiary of Cigna’s Evernorth,unveiled two new programs...
by Jessica Casebolt | Apr 14, 2023 | Access & Coverage, Tea Leaves
Missouri Attorney General Andrew Bailey issued new regulations Thursday severely limiting gender-affirming care for both adults and youth. The order institutes a three-year waiting period for medical intervention and requires psychological or psychiatric assessment....
by Jessica Casebolt | Apr 13, 2023 | Opioid/Substance Use Disorders, Tea Leaves
The Biden administration is declaring xylazine-laced fentanyl an official emerging drug threat to the nation, the first time any drug has been given that label. Xylazine, also known as “tranq,” is an easily accessible veterinary drug approved for use in animals as a...
Recent Comments